Biogen, Inc. (BIIB)
177.35
+1.33
(+0.76%)
USD |
NASDAQ |
Apr 17, 16:00
177.52
+0.17
(+0.10%)
After-Hours: 20:00
Biogen SG&A Expense (Quarterly) : 682.50M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.952B |
| Gilead Sciences, Inc. | 4.418B |
| Johnson & Johnson | 0.00 |
| Apellis Pharmaceuticals, Inc. | 147.10M |
| Moderna, Inc. | 308.00M |